$QPRC
QUEST PATENT RESEARCH CORP Stock $qprc

$qprc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024067714 Filed on August 12, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$900.0K	$850.0K
YoY Change	260.0%
Cost Of Revenue	$382.0K	$318.0K	$0.00
YoY Change	582.14%
Gross Profit	$248.5K	$463.4K	-$97.50K
YoY Change	-419.55%	-575.23%	-587.25%
Gross Profit Margin	27.61%	54.51%
Selling, General & Admin	$764.3K	$816.4K	$649.9K
YoY Change	27.74%	25.62%	20.91%
% of Gross Profit	307.58%	176.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$158.2K	$164.2K	$229.9K
YoY Change	-21.88%	-28.56%	11.95%
% of Gross Profit	63.67%	35.44%
Operating Expenses	$764.3K	$816.4K	$649.9K
YoY Change	27.74%	25.62%	20.91%
Operating Profit	-$515.8K	-$353.1K	-$747.4K
YoY Change	-23.7%	-52.76%	44.42%
Interest Expense	-$80.55K	$10.99K	-$422.2K
YoY Change	-48.77%	-102.6%	-241.9%
% of Operating Profit
Other Income/Expense, Net	-$80.54K	$10.99K	-$422.2K
YoY Change	-48.77%	-102.6%	-241.89%
Pretax Income	-$596.4K	-$342.1K	-$1.170M
YoY Change	-28.43%	-70.75%	431.8%
Income Tax	-$5.033K	$105.0K
% Of Pretax Income
Net Earnings	-$591.3K	-$447.1K	-$1.170M
YoY Change	-29.04%	-61.77%	431.8%
Net Earnings / Revenue	-65.7%	-52.6%
Basic Earnings Per Share	-$0.11	-$0.08	-$0.22
Diluted Earnings Per Share	-$0.11	-$0.08	-$0.22
COMMON SHARES
Basic Shares Outstanding	5.332M shares	5.332M shares	5.332M shares
Diluted Shares Outstanding	5.332M shares	5.332M shares	5.332M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$136.8K	$136.8K	$128.5K
YoY Change	-77.63%	6.44%	-43.68%
Cash & Equivalents	$136.8K	$136.8K	$128.5K
Short-Term Investments
Other Short-Term Assets	$87.91K	$83.64K	$33.36K
YoY Change	39.39%	150.73%	12.89%
Inventory
Prepaid Expenses			$33.36K
Receivables	$908.3K	$758.3K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.133M	$978.7K	$161.9K
YoY Change	67.96%	504.63%	-37.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$3.185M	$3.344M	$4.042M
YoY Change	-17.69%	-17.29%	272.26%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.185M	$3.344M	$4.042M
YoY Change	-17.69%	-17.29%	272.26%
TOTAL ASSETS
Total Short-Term Assets	$1.133M	$978.7K	$161.9K
Total Long-Term Assets	$3.185M	$3.344M	$4.042M
Total Assets	$4.318M	$4.322M	$4.204M
YoY Change	-4.98%	2.8%	212.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$547.8K	$538.7K	$206.4K
YoY Change	93.39%	160.99%	60.68%
Accrued Expenses	$1.024M	$878.7K	$1.254M
YoY Change	-30.26%	-29.96%	85.94%
Deferred Revenue
YoY Change
Short-Term Debt	$7.272M	$6.772M	$10.03M
YoY Change	-33.64%	-32.46%	30.66%
Long-Term Debt Due	$2.797M	$2.797M	$2.797M
YoY Change	0.0%	0.0%	-0.22%
Total Short-Term Liabilities	$11.81M	$11.23M	$14.64M
YoY Change	-25.26%	-23.33%	58.35%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$150.0K	$150.0K
YoY Change	0.0%	0.0%	1.08%
Other Long-Term Liabilities	$53.67K	$53.67K	$53.67K
YoY Change	0.0%	0.0%	-71.75%
Total Long-Term Liabilities	$203.7K	$203.7K	$203.7K
YoY Change	0.0%	0.0%	-39.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.81M	$11.23M	$14.64M
Total Long-Term Liabilities	$203.7K	$203.7K	$203.7K
Total Liabilities	$12.02M	$11.43M	$14.85M
YoY Change	-24.94%	-23.01%	54.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.38M	-$24.79M	-$28.30M
YoY Change	-12.88%	-12.4%	9.61%
Common Stock	$160.00	$160.00	$160.00
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.700M	-$7.109M	-$10.64M
YoY Change
Total Liabilities & Shareholders Equity	$4.318M	$4.322M	$4.204M
YoY Change	-4.98%	2.8%	212.91%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$591.3K	-$447.1K	-$1.170M
YoY Change	-29.04%	-61.77%	431.8%
Depreciation, Depletion And Amortization	$158.2K	$164.2K	$229.9K
YoY Change	-21.88%	-28.56%	11.95%
Cash From Operating Activities	-$500.0K	$892.8K	-$490.2K
YoY Change	19.46%	-282.16%	66.94%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	500.0K	-1.527M	491.7K
YoY Change	-46.32%	-410.48%	84.11%
NET CHANGE
Cash From Operating Activities	-500.0K	892.8K	-490.2K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	500.0K	-1.527M	491.7K
Net Change In Cash	20.00	-633.9K	1.600K
YoY Change	-100.0%	-39720.63%	-106.04%
FREE CASH FLOW
Cash From Operating Activities	-$500.0K	$892.8K	-$490.2K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$500.0K	$892.8K	-$490.2K
YoY Change	11.47%	-282.16%	66.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5331973	shares
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5331973	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5331973	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5331973	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	33-18099-NY
	dei	Entity Registrant Name EntityRegistrantName	QUEST PATENT RESEARCH CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2873662
	dei	Entity Address Address Line1 EntityAddressAddressLine1	411 Theodore Fremd Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 206S
	dei	Entity Address City Or Town EntityAddressCityOrTown	Rye
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10580-1411
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	743-7577
	dei	Security12b Title Security12bTitle	None
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5331973	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	136767	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	563484	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	758250	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3015295	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	83644	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28121	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	978661	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3606900	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2743495	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2412397	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3343505	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3674603	usd
CY2024Q2	us-gaap	Assets Assets	4322166	usd
CY2023Q4	us-gaap	Assets Assets	7281503	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	538744	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1674690	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6634381	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7325502	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	240615	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	281809	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	878653	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1096985	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11226893	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13313486	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	150000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	150000	usd
CY2024Q2	qprc	Purchase Price Of Patents PurchasePriceOfPatents	53665	usd
CY2023Q4	qprc	Purchase Price Of Patents PurchasePriceOfPatents	53665	usd
CY2024Q2	us-gaap	Liabilities Liabilities	11430558	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13517151	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00003
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00003
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00003
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00003
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5331973	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5331973	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5331973	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5331973	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	160	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	160	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17680793	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17674985	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24789573	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23911021	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-7108620	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6235876	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	228	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	228	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7108392	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6235648	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4322166	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7281503	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	850000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1895000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	202500	usd
CY2024Q2	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	386631	usd
CY2023Q2	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	97504	usd
	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	948183	usd
	qprc	Litigation And Licensing Expenses LitigationAndLicensingExpenses	285477	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	463369	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-97504	usd
	us-gaap	Gross Profit GrossProfit	946817	usd
	us-gaap	Gross Profit GrossProfit	-82977	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	816434	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	649904	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1393713	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1427761	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	816434	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	649904	usd
	us-gaap	Operating Expenses OperatingExpenses	1393713	usd
	us-gaap	Operating Expenses OperatingExpenses	1427761	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-353065	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-747408	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-446896	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1510738	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-240616	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	205486	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-41194	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	214052	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	229628	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	216752	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	367817	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	354221	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10988	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-422238	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-326623	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-568273	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-342077	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1169646	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-773519	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2079011	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105033	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105033	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-447110	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1169646	usd
	us-gaap	Profit Loss ProfitLoss	-878552	usd
	us-gaap	Profit Loss ProfitLoss	-2109011	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5331973	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5331973	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5331973	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5331973	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8562827	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	18573	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-939365	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9483619	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	9972	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1169646	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10643293	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6235648	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5808	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-431442	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6661282	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-447110	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7108392	usd
	us-gaap	Profit Loss ProfitLoss	-878552	usd
	us-gaap	Profit Loss ProfitLoss	-2109011	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-41194	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	214052	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5808	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28545	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	331098	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	388746	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2257045	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-218332	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	349834	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	55523	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	28043	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1135946	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	57883	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	264404	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1097994	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3300000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3300000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	834381	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	4500000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1525502	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	64110	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-691121	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4435890	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-426717	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	37896	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563484	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90601	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136767	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	128497	usd
	qprc	Interest Added To Principal InterestAddedToPrincipal	1402	usd
	qprc	Interest Added To Principal InterestAddedToPrincipal	2790	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	105033	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4386	usd
	us-gaap	Interest Paid Net InterestPaidNet	4386	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	758000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3015000	usd
	qprc	Reimbursement Costs Received ReimbursementCostsReceived	334000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105033	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105033	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash in bank deposit accounts, which at times, may exceed federally insured limits. The Company has not experienced any such losses in these accounts.</p>
	qprc	Dilutive Potential Common Shares DilutivePotentialCommonShares	962463	shares
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24789573	usd
CY2024Q2	qprc	Working Capital WorkingCapital	10248000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6087000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6087000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2743495	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2412397	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3343505	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3674603	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y25D
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y5M19D
CY2021Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	350000	usd
CY2021Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	350000	usd
CY2021Q1	qprc	Aggregate Amount AggregateAmount	93900	usd
CY2024Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	167000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	331000	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	230000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	389000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	305256	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	540589	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	500064	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	464786	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	397345	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1135465	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3343505	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	138000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6634381	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7325502	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	6402000	usd
CY2024Q2	qprc	Advance Operating Capital AdvanceOperatingCapital	0	usd
	qprc	Advance Operating Capital AdvanceOperatingCapital	200000	usd
CY2023Q1	qprc	Proceeds From Finance ProceedsFromFinance	3300000	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2796500	usd
CY2015Q4	qprc	Purchase Agreement PurchaseAgreement	4672810	usd
	qprc	Asset Acquired Description AssetAcquiredDescription	Under these MPAs, Intelligent Partners participates in the monetization proceeds the Company receives with respect to new patents after QFL and QF3 have received their negotiated rate of return.
	us-gaap	Notes Issued1 NotesIssued1	250000	usd
	us-gaap	Derivative Maturity Dates DerivativeMaturityDates	2050-05-14
	qprc	Deducted Loan Amount DeductedLoanAmount	100	usd
	qprc	Loan Origination Cost LoanOriginationCost	1000	usd
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	53665	usd
CY2023	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	53665	usd
CY2020Q2	qprc	Acquisition Funding Amount AcquisitionFundingAmount	95000	usd
	qprc	Funder Received FunderReceived	53665	usd
CY2021Q1	qprc	Minimum Warrant Yield Outstanding Shares Capital Stock Percentage MinimumWarrantYieldOutstandingSharesCapitalStockPercentage	0.10	pure
CY2021Q1	qprc	Increased To Aggregate Number Of Outstanding Shares Of Capital Sock IncreasedToAggregateNumberOfOutstandingSharesOfCapitalSock	0.10	pure
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	241000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	282000	shares
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	281809	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	199422	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	481231	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-240616	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	240615	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.39
CY2023Q4	qprc	Share Based Compensation Arrangements By Share Based Payment Award Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageGrantDateFairValue	1.2
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2000000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.39
CY2024Q2	qprc	Share Based Compensation Arrangements By Share Based Payment Award Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageGrantDateFairValue	1.2
	qprc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P5Y3M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1200000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.97
	qprc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Grant Date Fair Value Options Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageGrantDateFairValueOptionsExercisable	1.2
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y11M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	962463	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P7Y1M20D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	962463	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.54
	qprc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1	P6Y7M24D
	qprc	Outstanding Share Capital Percentage OutstandingShareCapitalPercentage	0.10	pure
CY2024Q2	qprc	Patent Service Costs PatentServiceCosts	30000	usd
	qprc	Patent Service Costs PatentServiceCosts	60000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	318000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	781000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	62000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	qprc	Share Based Compensation Arrangements By Share Based Payment Award Weighted Average Grant Date Fair Value Exercised ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageGrantDateFairValueExercised
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	qprc	Share Based Compensation Arrangements By Share Based Payment Award Weighted Average Grant Date Fair Value Expired ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageGrantDateFairValueExpired
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	qprc	Share Based Compensation Arrangements By Share Based Payment Award Weighted Average Grant Date Fair Value Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageGrantDateFairValueCancelled
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	qprc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedPeriod		shares
	qprc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExercised
	qprc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpired		shares
	qprc	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExpired
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000824416
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-067714-index-headers.html	Edgar Link	pending
0001213900-24-067714-index.html	Edgar Link	pending
0001213900-24-067714.txt	Edgar Link	pending
0001213900-24-067714-xbrl.zip	Edgar Link	pending
ea0210557-10q_quest.htm	Edgar Link	pending
ea021055701ex31-1_quest.htm	Edgar Link	pending
ea021055701ex32-1_quest.htm	Edgar Link	pending
ea0210557-10q_quest_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qprc-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qprc-20240630_cal.xml	Edgar Link	unprocessable
qprc-20240630_def.xml	Edgar Link	unprocessable
qprc-20240630_lab.xml	Edgar Link	unprocessable
qprc-20240630_pre.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QPRC
QUEST PATENT RESEARCH CORP Stock $qprc

2024 Q3 Form 10-Q Financial Statement

#000121390024067714 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QPRC QUEST PATENT RESEARCH CORP Stock $qprc

2024 Q3 Form 10-Q Financial Statement

#000121390024067714 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QPRC
QUEST PATENT RESEARCH CORP Stock $qprc